AuthorsBell, D W
Szydlo, T E
Kang, D H
Wahrer, D C
Shannon, K E
Verselis, S J
Isselbacher, K J
Fraumeni, J F
Birch, Jillian M
Li, F P
Garber, J E
Haber, Daniel A
AffiliationMassachusetts General Hospital Center for Cancer Risk Analysis and Harvard Medical School, Building 149, Charlestown, MA 02129, USA.
MetadataShow full item record
AbstractThe hCHK2 gene encodes the human homolog of the yeast Cds1 and Rad53 G2 checkpoint kinases, whose activation in response to DNA damage prevents cellular entry into mitosis. Here, it is shown that heterozygous germ line mutations in hCHK2 occur in Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in the TP53 gene. These observations suggest that hCHK2 is a tumor suppressor gene conferring predisposition to sarcoma, breast cancer, and brain tumors, and they also provide a link between the central role of p53 inactivation in human cancer and the well-defined G2 checkpoint in yeast.
CitationHeterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. 1999, 286 (5449):2528-31 Science
- Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome.
- Authors: Bougeard G, Limacher JM, Martin C, Charbonnier F, Killian A, Delattre O, Longy M, Jonveaux P, Fricker JP, Stoppa-Lyonnet D, Flaman JM, Frébourg T
- Issue date: 2001 Apr
- Checkpoint gene linked to human cancer.
- Authors: Hagmann M
- Issue date: 1999 Dec 24
- Li-Fraumeni syndrome: the genetics and treatment considerations for the sarcoma and associated neoplasms.
- Authors: Upton B, Chu Q, Li BD
- Issue date: 2009 Jan
- DNA damage-associated dysregulation of the cell cycle and apoptosis control in cells with germ-line p53 mutation.
- Authors: Goi K, Takagi M, Iwata S, Delia D, Asada M, Donghi R, Tsunematsu Y, Nakazawa S, Yamamoto H, Yokota J, Tamura K, Saeki Y, Utsunomiya J, Takahashi T, Ueda R, Ishioka C, Eguchi M, Kamata N, Mizutani S
- Issue date: 1997 May 15
- p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition.
- Authors: Vahteristo P, Tamminen A, Karvinen P, Eerola H, Eklund C, Aaltonen LA, Blomqvist C, Aittomäki K, Nevanlinna H
- Issue date: 2001 Aug 1